Chlorhexidine Antiseptic Irrigation of the Bowel Segment During Radical Cystectomy and Urinary Diversion
This is a single arm, interventional pilot study of using chlorhexidine irrigation
intra-operatively and post-operatively among patients undergoing radical cystectomy with
urinary diversion. The intervention comprises of using irrigation of ileal conduit or
ileal neo...
Age: 18 years - 66+
Gender: All
Persuasive Health Communication Intervention for HIV/HCV
A major impediment to emergency department (ED)-based HIV/HCV screening success is that
often ED patients at risk for, or later diagnosed with, HIV and HCV decline testing. In
this R01 project, the research team will assess how well a promising, easy-to-use,
one-time...
Age: 18 years - 66+
Gender: All
MTC Versus FMT in for RCDI
Investigating four different treatment of MTC or FMT
Age: 18 years - 66+
Gender: All
Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial
COVID-19 can trigger a dysregulated immune response, and previous studies have shown that
immune modulation can improve outcomes in hospitalized patients. This trial is designed
to determine whether intensification of immune modulation early in the course of the
dise...
Age: 18 years - 66+
Gender: All
The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection
The objective of this study is to understand the effects of HIV cure strategies on the virus
and immune cells that reside within the gastrointestinal tract. Subjects receiving therapies
with the potential for HIV cure will undergo a colonoscopy to obtain gastrointes...
Age: 18 - 75 years
Gender: All
Study of 2 Medicines (Aztreonam and Avibactam) Compared to Best Available Therapy for Serious Gram-negative Infections
The purpose of this study is to evaluate how Aztreonam (ATM) and Avibactam (AVI) are
processed in pediatric participants. This study also aims to understand participant
safety and effects in pediatric participants.
The study is seeking participants who are:
- 9...
Age: 9 months - 17 years
Gender: All
Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)
Treatments are needed to improve outcomes among patients hospitalized for COVID-19,
including direct-acting antiviral (DAA) agents to mitigate the pathology driven by
ongoing viral replication. This trial will evaluate S-217622 (ensitrelvir), an
anti-SARS-CoV2 3C-lik...
Age: 18 years - 66+
Gender: All
Study to Evaluate the Safety and Tolerability of Single-Dose Intravenous (IV) Oritavancin
This protocol describes a randomized, open-label study to evaluate the safety and
tolerability of single-dose intravenous (IV) oritavancin diphosphate (oritavancin) versus
standard of care (SoC) antibiotics for the treatment of pediatric subjects with acute
bacterial...
Age: 3 months - 17 years
Gender: All
Study Evaluating Safety, Tolerability, and Efficacy of Intravenous AP-SA02 in Subjects With S. Aureus Bacteremia
Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose
Escalation Study of the Safety, Tolerability, and Efficacy of Intravenous AP SA02 as an
Adjunct to Best Available Antibiotic Therapy Compared to Best Available Antibiotic
Therapy Alone...
Age: 18 years - 66+
Gender: All
Testing a Novel Data-to-Suppression (D2S) Intervention Strategy in the Ryan White HIV/AIDS Program
The Ryan White HIV/AIDS Program (RWHAP) for low-income people with HIV (PWH) is a key
resource for reducing HIV health disparities and scaling up evidence-based interventions. As
RWHAP serves >50% of US PWH, RWHAP outcomes are vital to achieving "getting-to-zero"/ E...
Age: Birth - 66+
Gender: All
Pediatric GVHD Low Risk Steroid Taper Trial
The standard treatment for acute graft-vs-host disease (GVHD) is to suppress the activity of
the donor immune cells using steroid medications such as prednisone. Although most GVHD,
especially in children, responds well to treatment, sometimes (around 1/3 of the tim...
Age: Birth - 21 years
Gender: All
An Open-Label, Phase 2 Trial of Nanatinostat in Combination With Valganciclovir in Patients With Epstein-Barr Virus-Positive (EBV+) Relapsed/Refractory Lymphomas
A Phase 2 study to evaluate the efficacy of nanatinostat in combination with valganciclovir
in patients with relapsed/refractory EBV-positive lymphomas
Age: 18 years - 66+
Gender: All
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
This clinical trial evaluates the usefulness of using a smartphone-based HIV-specific
smoking cessation intervention at the time of lung cancer screening in helping people
living with HIV quit smoking. Positively Smoke Free - Mobile may help patients with HIV
quit sm...
Age: 45 - 80 years
Gender: All
Impact of COVID-19 on GU Disease
The purpose of this research study is to identify patients with GU disease with active or
past COVID-19 infection.
Participants will be asked to:
- Complete an Online COVID-19 Questionnaire.
- Disclose if the patient has or had Genitourinary cancer or beni...
Age: 40 years - 66+
Gender: All
Early CPAP in COVID-19 Confirmed or Suspected Patients
There is surge in COVID infected patients in New York City with a shortage of hospital beds,
ICU beds and ventilators. Strategies to reduce the need for all of the above are immediately
needed. Further, few interventions are targeted in COVID infected patients early...
Age: 18 years - 66+
Gender: All
Early CPAP in COVID-19 Confirmed or Suspected Patients
There is surge in COVID infected patients in New York City with a shortage of hospital beds,
ICU beds and ventilators. Strategies to reduce the need for all of the above are immediately
needed. Further, few interventions are targeted in COVID infected patients early...
Age: 18 years - 66+
Gender: All
Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients
This study is being done to better understand whether or not cemiplimab by itself and in
combination with other treatments given prior to surgery will cause your tumor to respond
in a beneficial way; whether the drug(s) are safe and what side effects they cause; and
...
Age: 18 years - 66+
Gender: All
A Double-Masked, Placebo-Controlled, Randomized, Phase II Clinical Trial To Assess The Efficacy Of SCH1 In The Treatment Of Acute Infectious Conjunctivitis
Acute infectious conjunctivitis is a leading cause of ocular morbidity, epidemic eye infection, lost productivity, patient discomfort and in some cases permanent visual compromise. The infectious agent is frequently viral in origin and frequently bacterial in origin wit...
Age: 18 - 90 years
Gender: All
To Compare Ridinilazole Versus Vancomycin Treatment for Clostridium Difficile Infection
Summit is developing ridinilazole as a novel antimicrobial for Clostridium difficile
Infection (CDI), formerly known as Clostridium difficile Infection, with the goal of
achieving comparable cure rates to standard of care, but reducing rates of recurrent disease.
...
Age: 18 years - 66+
Gender: All
Fecal Microbiota Transplant National Registry
A national data registry of patients receiving fecal microbiota transplantation (FMT) or
other gut-related-microbiota products designed to prospectively assess short and long-term
safety and effectiveness
Age: Birth - 66+
Gender: All